SMR Stemless Reverse vs SMR Reverse Shoulder System
Limacorporate S.p.a · with NAMSA · NCT04697004
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 22+ · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Not applicable
- Target enrollment
- 200
- US sites recruiting
- 7
- Study start
- April 1, 2021
- Record last updated
- October 28, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The SMR Stemless Reverse is intended for total, primary shoulder joint replacement by reducing pain and restoring shoulder articular mobility function. This is a prospective, multi-center, randomized, controlled trial to demonstrate non-inferiority of the SMR Stemless Reverse to the SMR Reverse Shoulder System.
Patients with joint dysfunction who continue to experience significant symptoms despite an appropriate course of non-operative management are eligible. Patients will be considered enrolled into the study when an ICF has been signed, all inclusion criteria are met and no exclusion criteria are present including intraoperative exclusion criteria, and the patient is randomized into either the SMR Stemless Reverse (investigational) group, the SMR Reverse Shoulder System (control) group or is part of the roll-in population. Enrollment is expected to take approximately 24 months.
Being studied: Investigational Arm: SMR Stemless Reverse; Control Arm: SMR Reverse Shoulder System
Conditions: Arthroplasty, Replacement
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age ≥ 22 years of age
- Skeletally mature as evident by scapula and proximal humerus closure
- Candidate for primary total shoulder replacement in a grossly rotator cuff deficient joint with severe arthropathy (disabled shoulder), when clinical indications based on physical exam and medical history including one or more of the following:
- Arthritis with rotator cuff tear not reparable
- Irreparable rotator cuff tear
- Rotator cuff tear arthropathy
- Severe osteoarthritis and rotator cuff deficiency or stiff shoulder
- Significant glenoid or socket side bone deformed or loss
- Reoccurrence of instability or a chronic shoulder dislocation
- Any other medical reason that the investigator determine that subject is a good candidate for a reverse total shoulder arthroplasty
Exclusion Criteria
- BMI > 40 kg/m2
- Previous contralateral shoulder surgery within 3 months of enrollment or that requires active treatment (i.e. surgery or brace)
- Had surgery in the targeted shoulder within last 12 months of enrollment, except diagnostic arthroscopy without procedures
- Had surgery in lower limbs (such as hip or knee) within last 6 months of enrollment
- Corticosteroid injections in the ipsilateral shoulder within 3 months of enrollment
- Complete deltoid muscle insufficiency
- Glenoid retroversion great than 25 degrees based off a 2D axial CT scan
- History of/or signs and/or symptoms of local or systemic infection including but not limited to septicemia; osteomyelitis
- Neurologically confirmed nerve lesion compromising shoulder joint function
- Poor meta-epiphyseal bone stock compromising stability of the implant including but not limited to humeral head fracture, iatrogenic glenoid fracture, severe osteoporosis
- Metabolic disorders which may impair fixation and stability of the implant including but not limited to uncontrolled diabetes mellitus with an HbA1C > 7.5%
- Extended bone loss after previous surgery defined as: complete bone loss of greater and lesser tuberosity
- Meta-epiphyseal bony defect (including large cyst)
Recruiting US locations
Levy Shoulder Center
Boca Raton, FL 33428
Site contact: Janice Schuck
AdventHealth
Orlando, FL 32803
Site contact: Carissa Davy · Carissa.davy@adventhealth.com
Foundation for Orthopaedic Research and Education
Tampa, FL 33607
Site contact: Debbi Warren, RN, CCRC, ACRP-CP · 813-738-6457 · dwarren@foreonline.org
Central Indiana Orthopedics
Fishers, IN 46037
Site contact: Brad Crackel · Brad_crackel@ciocenter.com
Upstate Orthopedics
East Syracuse, NY 13057
Site contact: Tina Craig · 3154648618 · CraigT@upstate.edu
Rothman Orthopaedic
Philadelphia, PA 19107
Site contact: Thema Nicolson · (267) 339-3615 · Thema.Nicholson@rothmanortho.com
Guthrie
Sayre, PA 18840
Site contact: Brent Bloomquist · Brent.Bloomquist@guthrie.org
Study contacts (from the official record)
- Fabiana Pavan · +39 348 5816391 · Fabiana.Pavan@limacorporate.com
- Kelsey Breuning · kbreuning@namsa.com
Similar studies in Florida
All arthritis studies in Florida →- RecruitingHealthy volunteersPhase 1
A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis
Eli Lilly and Company
- Location
- Clearwater, FL + 8 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteersPhase 1
Sustained Acoustic Medicine for Osteoarthritis Pain
ZetrOZ, Inc.
- Location
- Tampa, FL
- Eligibility basics
- Ages 35–85
- RecruitingPhase 1/Phase 2
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Nkarta, Inc.
- Location
- Plantation, FL + 11 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Crystalys Therapeutics
- Location
- Bradenton, FL + 82 other US sites
- Eligibility basics
- Ages 18–75